Commercially prepared polyclonal antisera to Legionella pneumophila are known to cross-react with organisms of the genus Pseudomonas. To determine whether a commercially available monoclonal antibody reagent specific for L. pneumophila would also cross-react with pseudomonads, a two-laboratory study was undertaken to test both monoclonal and polyclonal reagents against 33 isolates of Pseudomonas spp., including 25 Pseudomonas aeruginosa, 4 P. putida, 2 P. maltophilia, 1 P. fluorescens, and 1 P. alcaligenes. Four antisera were tested; polyclonal anti-legionella antisera pools A and B (Centers for Disease Control [CDC], Atlanta, Ga.), polyclonal 1-6 antisera (BioDx, Inc., Denville, N.J.), and a monoclonal antibody reagent produced by Genetic Systems Corp., Seattle, Wash. All reagents were labeled with fluorescein. Cross-staining reactions were found with the BioDx L. pneumophila antisera and 10 isolates of Pseudomonas. Four of these isolates demonstrated cross-staining with CDC pool A. When tested with individual serotype-specific reagents (CDC), three of four cross-reacted with L. pneumophila serotype 1 antisera; the fourth cross-reacted with serotype 3. No cross-staining reactions were noted with the monoclonal reagent and any of the pseudomonads tested, demonstrating that the Genetic Systems Corp. monoclonal reagent is the most specific of the four reagents tested.
The diagnosis of legionella pneumonia is most readily established by the direct detection of the causative agent in respiratory secretions, tissues, or fluids by using fluoresceinlabeled legionella antisera (2, 6, 10) . Several investigators have noted, however, that such antisera may cross-react with nonlegionella organisms, including several species of Pseudomonas, occasional Bacteroides spp., and members of the Flavobacterium-Xanthomonas group (1, 5, 11) , resulting in false-positive reactions.
Our previous evaluations of the monoclonal legionella reagent developed by Genetic Systems Corp., Seattle, Wash. (GSC) demonstrated it to produce more uniform staining patterns around legionella bacilli and to produce more definitive staining of Legionella pneumophila serogroups 7, 8, and 9 than a polyclonal reagent (12) . However, problems with cross-reactions between the polyclonal and monoclonal reagents and Pseudomonas spp. were not addressed. To determine whether such cross-reactions are less common with a monoclonal legionella reagent, the Seattle and Los Angeles (Wadsworth) Veterans Administration Medical Centers (SVAMC and LAVAMC) tested 33 isolates of Pseudomonas spp. with three different polyclonal legionella antisera and one monoclonal antibody reagent specific for L. pneumophila (9) .
The 33 study organisms (Table 1) 37°C , and grew on cetrimide slants. Organisms which did not fit these criteria were identified by additional procedures described by Gilardi (7, 8) including: indophenol oxidase; growth on MacConkey agar (Difco) at 37°C; production of DNase, lysine decarboxylase, and arginine dihydrolase; liquification of gelatin; reduction of nitrate to nitrite or gas; hydrolysis of urea, o-nitrophenyl-P-Dgalactopyranoside, or casein; oxidation of glucose, maltose, xylose, or mannitol; and motility. The number and arrangement of flagella for each non-P. aeruginosa isolate was determined by electron microscopy.
All study isolates were initially tested with BioDx L. pneumophila polyclonal 1-6 reagent and with GSC L. pneumophila reagent according to the package inserts. Both reagents are fluorescein labeled. The slides were examined with a 40x glycerol immersion objective and lOx eyepieces (at SVAMC total magnification, 400x) or a 40x dry objective with a cover slip in conjunction with 12.5 These results demonstrate that the GSC monoclonal reagent is more specific than are the CDC or BioDx polyclonal reagents. The cross-reactivity of the polyclonal reagents is already known (5, 11). Collins and co-workers (3) have identified shared antigens between several Legionella species and a P. aeruginosa common antigen by using serum from rabbits hyperimmunized with different Legionella species. The GSC monoclonal reagent apparently does not react with this P. aeruginosa common antigen and thus holds promise for greater diagnostic accuracy than the polyvalent antisera. The recent study of frozen respiratory tract specimens with the GSC monoclonal antiserum demonstrated the monoclonal reagent to be as sensitive and specific as polyclonal reagents (4) . The data reported here suggest that the monoclonal reagent, in fact, is more specific than the polyclonal reagents, making it the preferred reagent for diagnostic use. It is unclear to us whether the weak-inten-sity cross-reactions noted with some of the pseudomonas isolates would cause confusion in diagnostic testing, although false-positive reactions with at least some Pseudomonas spp. undoubtably occur in clinical specimens. Specimens demonstrating low-intensity fluorescence around bacilli morphologically consistant with legionella should initiate a request for additional specimens for further testing.
In summary, the GSC reagent did not exhibit any crossstaining with a variety of Pseudomonas spp., including several organisms noted previously to cross-stain with other L. pneumophila typing sera.
